Clinical research conductor ICON Plc downplayed impacts from demand softness from the pharmaceutical and biotechnology industries, surprising investors with a $100 million revenue shortfall that led ...

Vetigenics is seeing encouraging results of a completed study for an antibody aimed at treating oral melanoma in dogs, used ...

Stuart Arbuckle, who’s been with Vertex since 2012, plans to retire from his role in July. His departure comes as Vertex ...

The FDA has made some modest efforts, but it needs an internal organization that understands and would be an aggressive ...

While billions pour into pharmaceutical biotech, officials and experts warn there’s much less private investment in products more relevant to the military, like body armor materials, anti-corrosion ...

The aggregate gross proceeds to the Company from the offering are expected to be approximately $1.05 million, before ...

On the lookout for a Sector - Health fund? Starting with Fidelity Select Biotechnology (FBIOX) is one possibility. FBIOX has a Zacks Mutual Fund Rank of 1 (Strong Buy), which is based on various ...

If you're interested in broad exposure to the Healthcare - Biotech segment of the equity market, look no further than the First Trust NYSE Arca Biotechnology ETF (FBT), a passively managed exchange ...

National Testing Agency (NTA) has invited Online Applications for Graduate Aptitude Test- Biotechnology (GAT-B) – 2025, a ...

Stratos Wealth Partners LTD. trimmed its position in shares of iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 17.9% ...